2225 — Jinhai Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$20.15bn
- HK$20.02bn
- SG$46.28m
Annual cashflow statement for Jinhai Medical Technology, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.062 | 0.784 | -3.22 | -18.2 | -17.2 |
| Depreciation | |||||
| Non-Cash Items | 2.57 | 2.88 | 4.36 | 16.4 | 12.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.59 | -0.806 | -4.18 | -2.97 | -2.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.34 | 4.24 | -1.91 | -3.25 | -5.57 |
| Capital Expenditures | -0.607 | -1.18 | -1.24 | -1.01 | -0.095 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.04 | 0.027 | -5.27 | -8.21 | 3.69 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.64 | -1.15 | -6.51 | -9.22 | 3.59 |
| Financing Cash Flow Items | -0.132 | 0.109 | -0.16 | -0.354 | -0.675 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.81 | -3.72 | 13.6 | 2.93 | 26.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.99 | -0.872 | 4.81 | -9.75 | 25.1 |